Company: TYRA
Filing Date: 2025-04-18
Form Type: DEF 14A
Source: 0001193125-25-085709
Chunk: 43

Company: Tyra Biosciences, Inc.
Filing Date: 2025-04-18
Form: DEF 14A
Chunk 43
---
27</div>

Clawback Policy In accordance with updated Nasdaq listing standards, our board of directors adopted a clawback policy applicable to incentive-based compensation granted to current and former executive officers of the Company, effective in October 2023. In the event of an accounting restatement to correct the Company’s material noncompliance with a financial reporting requirement, our clawback policy requires the Company to seek recovery of incentive-based compensation paid during the last three completed fiscal years in excess of what otherwise would have been received by any current or former executive officer based on a restated financial reporting measure, calculated on a pre-taxbasis, other than in limited circumstances. The policy grants the board of directors or designated committee of the board of directors discretion to determine the manner of recovery.

Equity Award Timing Policies and Practices Equity awards to employees are typically granted in connection with the Company annual award process in the third quarter of each year, as well as to new hires in connection with their commencement of employment. For new hires who are not executive officers, equity awards are typically made on the first trading day of the month immediately following the month of hire. We do not grant equity awards in anticipation of the release of material nonpublic information and we do not timethe release of material nonpublic information for the purpose of affecting the value of executive compensation.In the event material nonpublic information becomes known to the Compensation Committee before granting an equity award, the Compensation Committee will consider such information and use its business judgment to determine whether to delay the grant of equity to avoid any appearance of impropriety. For all stock option awards, the exercise price is the closing price of our Common Stock on the Nasdaq Stock Market on the date of the grant (or if the grant date is not a trading day, then on the immediately preceding trading day). During 2024, we did not grant stock options, stock appreciation rights, or similar option-likeinstruments to our NEOs during the four business days prior to or the one business day following the filing of our periodic reports or the filing or furnishing of a Form 10-K, 10-Q,or Form 8-Kthat discloses material nonpublic information. Non-EmployeeDirector Compensation Our Board and our stockholders have adopted a non-employeedirector compensation policy, as amended from time to time by our Board, which provides for annual retainer fees and/or long-term equity awards for our non-employeedirectors. In May 2024, our Board amended and restated the non-employeedirector compensation